BVF Inc
- SEC CIK
- 0001056807
- 最新申報
- 2026/8/14
2021 年第 4 季持倉
持倉截至 2021/12/31，2022/2/14 申報。只含多頭部位，變化是跟 2021 年第 3 季比股數。
- 持股檔數
- 83
- 較 2021 年第 3 季 +8
- 總值
- $27.6 億
- 較 2021 年第 3 季 +$1.92 億 (+7.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| GHRSGH Research PLC | ORDINARY SHARES | 9,275,158 | $2.16 億 | 7.9% | 00.0% | 不變 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 3,180,658 | $2.02 億 | 7.3% | 00.0% | 不變 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 3,398,067 | $1.38 億 | 5.0% | +168,245+5.2% | 加碼 | 歷史 |
| MRUSMerus N.V. | COM | 4,135,071 | $1.31 億 | 4.8% | +4,135,071 | 新進 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 3,651,759 | $1.25 億 | 4.5% | −250,000−6.4% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 3,289,540 | $1.03 億 | 3.7% | +1,717,762+109.3% | 加碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 4,858,761 | $1.02 億 | 3.7% | +1,136,363+30.5% | 加碼 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 3,130,605 | $9,614 萬 | 3.5% | +1,081,492+52.8% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 3,003,879 | $8,534 萬 | 3.1% | +2,050,000+214.9% | 加碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 5,369,459 | $8,285 萬 | 3.0% | +4,634,353+630.4% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 216,204 | $7,571 萬 | 2.7% | −150,000−41.0% | 減碼 | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 3,530,543 | $7,361 萬 | 2.7% | 00.0% | 不變 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 7,411,503 | $6,937 萬 | 2.5% | +750,000+11.3% | 加碼 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 1,156,393 | $6,375 萬 | 2.3% | +36,660+3.3% | 加碼 | 歷史 |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 14,360,000 | $5,658 萬 | 2.1% | 00.0% | 不變 | 歷史 |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 16,459,965 | $5,547 萬 | 2.0% | +5,052,783+44.3% | 加碼 | 歷史 |
| EQRXEQRx, Inc. | COM | 7,859,670 | $5,360 萬 | 1.9% | +7,859,670 | 新進 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,099,714 | $4,596 萬 | 1.7% | −386,715−15.6% | 減碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 1,810,549 | $4,557 萬 | 1.7% | −674,500−27.1% | 減碼 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 2,005,862 | $4,401 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 2,851,461 | $4,049 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 2,957,807 | $3,810 萬 | 1.4% | 00.0% | 不變 | – |
| VRDNViridian Therapeutics, Inc. | COM | 1,879,412 | $3,716 萬 | 1.3% | +1,075,286+133.7% | 加碼 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 1,647,400 | $3,712 萬 | 1.3% | +1,647,400 | 新進 | 歷史 |
| VSTMVerastem, Inc. | COM | 17,062,158 | $3,498 萬 | 1.3% | +2,084,900+13.9% | 加碼 | 歷史 |
| ACIUAC Immune SA | SHS | 7,062,379 | $3,496 萬 | 1.3% | +127,200+1.8% | 加碼 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 1,800,000 | $2,936 萬 | 1.1% | +1,800,000 | 新進 | 歷史 |
| KURAKura Oncology, Inc. | COM | 2,064,212 | $2,890 萬 | 1.0% | +429,100+26.2% | 加碼 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 1,873,332 | $2,636 萬 | 1.0% | +178,399+10.5% | 加碼 | 歷史 |
| SPROSpero Therapeutics, Inc. | COM | 1,585,615 | $2,539 萬 | 0.9% | −223,737−12.4% | 減碼 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 5,803,700 | $2,513 萬 | 0.9% | +5,803,700 | 新進 | 歷史 |
| REPLReplimune Group, Inc. | COM | 926,529 | $2,511 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 1,695,904 | $2,466 萬 | 0.9% | +322,860+23.5% | 加碼 | 歷史 |
| IMAImageneBio, Inc. | COM | 1,798,371 | $2,255 萬 | 0.8% | −33,700−1.8% | 減碼 | 歷史 |
| CTICCti Biopharma Corp | COM | 8,929,690 | $2,215 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,589,495 | $2,202 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 899,392 | $2,172 萬 | 0.8% | −247,660−21.6% | 減碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 6,631,051 | $2,129 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| Pieris Pharmaceuticals Inc720795103 | COM | 5,328,239 | $2,014 萬 | 0.7% | 00.0% | 不變 | – |
| JANXJanux Therapeutics, Inc. | COM | 1,017,314 | $2,007 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 1,791,351 | $1,965 萬 | 0.7% | +1,791,351 | 新進 | 歷史 |
| Calliditas Therapeutics AB13124Q106 | SPONSERED ADS | 750,000 | $1,857 萬 | 0.7% | 00.0% | 不變 | – |
| NGMNGM Biopharmaceuticals Inc | COM | 955,000 | $1,691 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 2,920,526 | $1,636 萬 | 0.6% | +148,300+5.3% | 加碼 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 666,666 | $1,560 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| INFIInfinity Pharmaceuticals, Inc. | COM | 6,353,645 | $1,430 萬 | 0.5% | −2,030,000−24.2% | 減碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 925,148 | $1,377 萬 | 0.5% | +98,323+11.9% | 加碼 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 9,544,262 | $1,374 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 809,282 | $1,364 萬 | 0.5% | −1,002−0.1% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,532,282 | $1,315 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| VIRXViracta Therapeutics, Inc. | COM | 3,438,944 | $1,255 萬 | 0.5% | +344,770+11.1% | 加碼 | 歷史 |
| MTEMMolecular Templates, Inc. | COM | 3,129,599 | $1,227 萬 | 0.4% | +273,000+9.6% | 加碼 | 歷史 |
| CFRXCONTRAFECT Corp | COM NEW | 3,972,300 | $1,045 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 1,611,698 | $970.2 萬 | 0.4% | +21,400+1.3% | 加碼 | 歷史 |
| LITSLite Strategy, Inc. | COM NEW | 3,532,057 | $943.1 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CDTXCidara Therapeutics, Inc. | COM | 6,861,127 | $871.4 萬 | 0.3% | +2,084,223+43.6% | 加碼 | 歷史 |
| MOLNMolecular Partners AG | ADS | 443,221 | $855.0 萬 | 0.3% | +24,213+5.8% | 加碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 448,512 | $854.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| IVAInventiva S.A. | ADS | 544,500 | $743.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CNCEConcert Pharmaceuticals, Inc. | COM | 2,253,000 | $709.7 萬 | 0.3% | +2,253,000 | 新進 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 435,936 | $695.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,378,020 | $607.7 萬 | 0.2% | +14,585+1.1% | 加碼 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM | 1,723,133 | $561.7 萬 | 0.2% | +1,403,455+439.0% | 加碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 454,545 | $511.8 萬 | 0.2% | +454,545 | 新進 | 歷史 |
| Eucrates Biomedical Acqu CorG3141W114 | UNIT 10/23/2027 | 500,000 | $499.0 萬 | 0.2% | 00.0% | 不變 | – |
| CALACalithera Biosciences, Inc. | COM | 7,452,331 | $495.7 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 500,000 | $495.0 萬 | 0.2% | 00.0% | 不變 | – |
| 5 01 Acquisition Corp33836P105 | COM CL A | 500,000 | $492.5 萬 | 0.2% | 00.0% | 不變 | – |
| RACBResearch Alliance Corp. II | COM CL A | 500,000 | $486.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| GNCAGenocea Biosciences, Inc. | COM NEW | 4,012,404 | $465.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 1,370,947 | $330.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| EOCNGalmed Pharmaceuticals Ltd. | SHS | 1,799,694 | $327.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ELTXElicio Therapeutics, Inc. | COM | 1,071,297 | $310.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Erytech Pharma29604W108 | SPONSORED ADR | 1,314,656 | $310.3 萬 | 0.1% | 00.0% | 不變 | – |
| RNTXRein Therapeutics, Inc. | COM | 5,265,555 | $296.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| JYACJiya Acquisition Corp. | COM CL A | 300,000 | $293.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Forward Pharma A/S34986J204 | SPONSORD ADS NEW | 432,892 | $258.4 萬 | 0.1% | 00.0% | 不變 | – |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 289,663 | $195.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 847,879 | $194.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| GBIOGeneration Bio Co. | COM | 189,050 | $133.8 萬 | <0.1% | +189,050 | 新進 | 歷史 |
| BNOXBionomics Ltd | ADS | 80,971 | $101.6 萬 | <0.1% | +80,971 | 新進 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 190,815 | $91.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| VYGRVoyager Therapeutics, Inc. | COM | 22,200 | $6.00 萬 | <0.1% | +22,200 | 新進 | 歷史 |
2021 年第 3 季之後清倉（3 檔）
2021 年第 3 季季末還持有、這份申報已經沒有的部位。